Quick Answer
LISATA THERAPEUTICS, INC. reported Diluted EPS of $1.91 per share (loss) for fiscal year 2025.
LISATA THERAPEUTICS, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.91 | +20.4% |
| 2024 | -$2.40 | +7.0% |
| 2023 | -$2.58 | +75.4% |
| 2022 | -$10.47 | -40.5% |
| 2021 | -$7.45 | -1305.7% |
| 2020 | -$0.53 | -120.7% |
| 2017 | $2.56 | +151.3% |
| 2016 | -$4.99 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.49 | +16.9% | +9.3% |
| June 30, 2025 | -$0.54 | +11.5% | +1.8% |
| March 31, 2025 | -$0.55 | +15.4% | +6.8% |
| September 30, 2024 | -$0.59 | +9.2% | +3.3% |
| June 30, 2024 | -$0.61 | -22.0% | +6.2% |
| March 31, 2024 | -$0.65 | +15.6% | +0.0% |
| September 30, 2023 | -$0.65 | +91.8% | -30.0% |
| June 30, 2023 | -$0.50 | +69.5% | +35.1% |
- LISATA THERAPEUTICS, INC. showed an increase of +20.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2016–2025 period, LISATA THERAPEUTICS, INC.’s diluted eps has grown by 61.7% (from $4.99 per share (loss) to $1.91 per share (loss)).
- The most recent figure is from LISATA THERAPEUTICS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: